The medical fraternity has found a new hope in the treatment of Scattered Abdomen Cancer, thanks to a new technique that has been embraced by 28 hospitals worldwide. Scattered Abdomen Cancer is a type of cancer that spreads through the abdominal cavity.
It is highly metastatic and difficult to treat. However, the new technique has shown promising results in treating the disease and improving the quality of life of patients.
What is Scattered Abdomen Cancer?
Scattered Abdomen Cancer is a type of cancer that begins in the abdominal cavity and spreads throughout the abdomen. The cancerous cells grow uncontrollably and can invade surrounding organs and tissues.
The cancer cells can also spread to other parts of the body through the bloodstream or lymphatic system. Scattered Abdomen Cancer is a highly metastatic cancer that is difficult to treat and has a low survival rate.
Current Treatment Options
The current treatment options for Scattered Abdomen Cancer include chemotherapy, radiation therapy, and surgery. However, these treatment options have limited effectiveness in treating the disease, and many patients experience adverse side effects.
The New Technique
The new technique involves the use of a specialized device that delivers heated chemotherapy directly into the abdominal cavity. The device is called the Hyperthermic Intraperitoneal Chemotherapy (HIPEC) system.
The HIPEC system is a closed circuit system that allows the surgeon to deliver heated chemotherapy directly into the abdominal cavity. The chemotherapy is heated to a temperature of 42 degrees Celsius, which helps to increase its effectiveness.
How HIPEC Works
The HIPEC procedure involves several steps. First, the surgeon administers general anesthesia to the patient. Next, the surgeon makes a large incision in the abdomen to gain access to the abdominal cavity.
The surgeon then removes any visible tumors from the abdominal cavity. After the tumors are removed, the HIPEC machine is connected to the abdominal cavity. The chemotherapy solution is then heated to 42 degrees Celsius and circulated throughout the abdominal cavity for 90 minutes.
The temperature is monitored throughout the procedure to ensure that it remains within safe limits.
The Benefits of HIPEC
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) has many benefits over traditional chemotherapy and radiation therapy.
First, HIPEC can deliver chemotherapy directly into the abdominal cavity, which allows for a higher concentration of chemotherapy to be delivered to the cancer cells. Second, the chemotherapy is heated, which helps to increase its effectiveness.
Third, the HIPEC procedure can be performed in conjunction with surgery, which allows the surgeon to remove any visible tumors from the abdominal cavity before administering the chemotherapy.
The Results
The results of the HIPEC procedure have been promising. Studies have shown that the HIPEC procedure can significantly improve the survival rates of patients with Scattered Abdomen Cancer.
The procedure has also been shown to improve the quality of life of patients by reducing the side effects associated with traditional chemotherapy and radiation therapy.
Conclusion
The new technique of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) has revolutionized the treatment of Scattered Abdomen Cancer. The procedure has shown promising results in improving the survival rates and quality of life of patients.
With 28 hospitals worldwide embracing the technique, there is hope that more patients will be able to benefit from this breakthrough in cancer treatment.